Association for Research in Vision and Ophthalmology
Association for Research in Vision and Ophthalmology
April 30, 2018
1 min read

Scleral implants may improve near visual acuity in patients with presbyopia

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

HONOLULU — A subset of patients treated for presbyopia with scleral implants experienced a clinically significant improvement in near visual acuity, according to a poster presented at the Association for Research in Vision and Ophthalmology meeting here.

“Preliminary data indicates that VisAbility micro-insert system (Refocus Group) may significantly improve near vision,” Frank A. Bucci Jr., MD, wrote in the poster.

Researchers evaluated visual acuity of a subsample of 20 patients from two centers in a multicenter FDA trial who received scleral implants and were followed for 24 months.

All 20 primary eyes achieved distance corrected near visual acuity of 20/40 or better at 40 cm at the final follow-up. Additionally, 92.5% of the primary eyes achieved an improvement of at least 10 ETDRS letters of near visual acuity, Bucci wrote in the poster.

For uncorrected near visual acuity, 100% of eyes achieved 20/32 or better and 90% achieved 20/25 or better. – by Robert Linnehan


Bucci FA. Scleral implants improved near visual acuity: A subsample of patients treated for presbyopia. Presented at: Association for Research in Vision and Ophthalmology annual meeting; April 28-May 3, 2018; Honolulu.

Disclosure: Bucci reports he is a clinical investigator in the VisAbility trial.